Differential Noradrenergic Modulation of Monetary Reward and Visual Erotic Stimulus Processing

We recently investigated the effects of the noradrenergic antidepressant reboxetine and the antipsychotic amisulpride compared to placebo on neural correlates of primary reinforcers by visual erotic stimulation in healthy subjects. Whereas, amisulpride left subjective sexual functions and correspond...

Full description

Bibliographic Details
Main Authors: Heiko Graf, Maike Wiegers, Coraline D. Metzger, Martin Walter, Birgit Abler
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-07-01
Series:Frontiers in Psychiatry
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fpsyt.2018.00346/full
_version_ 1818570554332938240
author Heiko Graf
Maike Wiegers
Coraline D. Metzger
Coraline D. Metzger
Coraline D. Metzger
Martin Walter
Birgit Abler
author_facet Heiko Graf
Maike Wiegers
Coraline D. Metzger
Coraline D. Metzger
Coraline D. Metzger
Martin Walter
Birgit Abler
author_sort Heiko Graf
collection DOAJ
description We recently investigated the effects of the noradrenergic antidepressant reboxetine and the antipsychotic amisulpride compared to placebo on neural correlates of primary reinforcers by visual erotic stimulation in healthy subjects. Whereas, amisulpride left subjective sexual functions and corresponding neural activations unimpaired, attenuated neural activations were observed under reboxetine within the nucleus accumbens (Nacc) along with diminished behavioral sexual functioning. However, a global dampening of the reward system under reboxetine seemed not intuitive considering the complementary role of the noradrenergic to the dopamine system in reward-related learning mediated by prediction error processing. We therefore investigated the sample of 17 healthy males in a mean age of 23.8 years again by functional magnetic resonance imaging (fMRI), to explore the noradrenergic effects on neural reward prediction error signaling. Participants took reboxetine (4 mg/d), amisulpride (200 mg/d), and placebo each for 7 days within a randomized, double-blind, within-subject cross-over design. During fMRI, we used an established monetary incentive task to assess neural reward expectation and prediction error signals within the bilateral Nacc using an independent anatomical mask for a region of interest (ROI) analysis. Activations within the same ROI were also assessed for the erotic picture paradigm. We confirmed our previous results from the whole brain analysis for the selected ROI by significant (p < 0.05 FWE-corrected) attenuated activations within the Nacc during visual sexual stimulation under reboxetine compared to placebo. However, activations in the Nacc concerning prediction error processing and monetary reward expectation were unimpaired under reboxetine compared to placebo, along with unimpaired reaction times in the reward task. For both tasks, neural activations and behavioral processing were not altered by amisulpride compared to placebo. The observed attenuated neural activations within the Nacc during visual erotic stimulation along with unimpaired neural prediction error and monetary reward expectation processing provide evidence for a differential modulation of the neural reward system by the noradrenergic agent reboxetine depending on the presence of primary reinforcers such as erotic stimuli in contrast to secondary such as monetary rewards.
first_indexed 2024-12-14T13:43:17Z
format Article
id doaj.art-599beb815a944f3bbebfe0527aaeb108
institution Directory Open Access Journal
issn 1664-0640
language English
last_indexed 2024-12-14T13:43:17Z
publishDate 2018-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Psychiatry
spelling doaj.art-599beb815a944f3bbebfe0527aaeb1082022-12-21T22:59:23ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402018-07-01910.3389/fpsyt.2018.00346334197Differential Noradrenergic Modulation of Monetary Reward and Visual Erotic Stimulus ProcessingHeiko Graf0Maike Wiegers1Coraline D. Metzger2Coraline D. Metzger3Coraline D. Metzger4Martin Walter5Birgit Abler6Department of Psychiatry and Psychotherapy III, Ulm University, Ulm, GermanyDepartment of Psychiatry and Psychotherapy III, Ulm University, Ulm, GermanyDepartment of Psychiatry, Otto von Guericke University, Magdeburg, GermanyInstitute of Cognitive Neurology and Dementia Research, Otto von Guericke University, Magdeburg, GermanyGerman Center for Neurodegenerative Diseases, Bonn, GermanyDepartment of Psychiatry, Eberhard Karls University, Tuebingen, GermanyDepartment of Psychiatry and Psychotherapy III, Ulm University, Ulm, GermanyWe recently investigated the effects of the noradrenergic antidepressant reboxetine and the antipsychotic amisulpride compared to placebo on neural correlates of primary reinforcers by visual erotic stimulation in healthy subjects. Whereas, amisulpride left subjective sexual functions and corresponding neural activations unimpaired, attenuated neural activations were observed under reboxetine within the nucleus accumbens (Nacc) along with diminished behavioral sexual functioning. However, a global dampening of the reward system under reboxetine seemed not intuitive considering the complementary role of the noradrenergic to the dopamine system in reward-related learning mediated by prediction error processing. We therefore investigated the sample of 17 healthy males in a mean age of 23.8 years again by functional magnetic resonance imaging (fMRI), to explore the noradrenergic effects on neural reward prediction error signaling. Participants took reboxetine (4 mg/d), amisulpride (200 mg/d), and placebo each for 7 days within a randomized, double-blind, within-subject cross-over design. During fMRI, we used an established monetary incentive task to assess neural reward expectation and prediction error signals within the bilateral Nacc using an independent anatomical mask for a region of interest (ROI) analysis. Activations within the same ROI were also assessed for the erotic picture paradigm. We confirmed our previous results from the whole brain analysis for the selected ROI by significant (p < 0.05 FWE-corrected) attenuated activations within the Nacc during visual sexual stimulation under reboxetine compared to placebo. However, activations in the Nacc concerning prediction error processing and monetary reward expectation were unimpaired under reboxetine compared to placebo, along with unimpaired reaction times in the reward task. For both tasks, neural activations and behavioral processing were not altered by amisulpride compared to placebo. The observed attenuated neural activations within the Nacc during visual erotic stimulation along with unimpaired neural prediction error and monetary reward expectation processing provide evidence for a differential modulation of the neural reward system by the noradrenergic agent reboxetine depending on the presence of primary reinforcers such as erotic stimuli in contrast to secondary such as monetary rewards.https://www.frontiersin.org/article/10.3389/fpsyt.2018.00346/fullfMRIprimary rewardsecondary rewardreboxetineamisulpridehealthy
spellingShingle Heiko Graf
Maike Wiegers
Coraline D. Metzger
Coraline D. Metzger
Coraline D. Metzger
Martin Walter
Birgit Abler
Differential Noradrenergic Modulation of Monetary Reward and Visual Erotic Stimulus Processing
Frontiers in Psychiatry
fMRI
primary reward
secondary reward
reboxetine
amisulpride
healthy
title Differential Noradrenergic Modulation of Monetary Reward and Visual Erotic Stimulus Processing
title_full Differential Noradrenergic Modulation of Monetary Reward and Visual Erotic Stimulus Processing
title_fullStr Differential Noradrenergic Modulation of Monetary Reward and Visual Erotic Stimulus Processing
title_full_unstemmed Differential Noradrenergic Modulation of Monetary Reward and Visual Erotic Stimulus Processing
title_short Differential Noradrenergic Modulation of Monetary Reward and Visual Erotic Stimulus Processing
title_sort differential noradrenergic modulation of monetary reward and visual erotic stimulus processing
topic fMRI
primary reward
secondary reward
reboxetine
amisulpride
healthy
url https://www.frontiersin.org/article/10.3389/fpsyt.2018.00346/full
work_keys_str_mv AT heikograf differentialnoradrenergicmodulationofmonetaryrewardandvisualeroticstimulusprocessing
AT maikewiegers differentialnoradrenergicmodulationofmonetaryrewardandvisualeroticstimulusprocessing
AT coralinedmetzger differentialnoradrenergicmodulationofmonetaryrewardandvisualeroticstimulusprocessing
AT coralinedmetzger differentialnoradrenergicmodulationofmonetaryrewardandvisualeroticstimulusprocessing
AT coralinedmetzger differentialnoradrenergicmodulationofmonetaryrewardandvisualeroticstimulusprocessing
AT martinwalter differentialnoradrenergicmodulationofmonetaryrewardandvisualeroticstimulusprocessing
AT birgitabler differentialnoradrenergicmodulationofmonetaryrewardandvisualeroticstimulusprocessing